David A. Eberhard

51 papers receiving 6.8k citations

David A. Eberhard's Hit Papers

Diverse somatic mutation patterns and pathway alterations in human cancers 2010 · 891 citations
8910+7+14Years since publication4008001.2k

Peers

David A. Eberhard
Comparison fields: 5 of 119
  • Pulmonary and Respiratory Medicine 2.1k
  • Genetics 447
  • Cancer Research 666
  • Oncology 1.1k
  • Cell Biology 455
Replace J. Guillermo Paez with:
J. Guillermo Paez United States
Elisabeth Dawson United Kingdom
Philip Jonsson United States
Michael Prados United States
Richard Mitter United Kingdom
Sandra Pastorino United States
Tamara Levin Lotan United States
Karen M. Cichowski United States
Stephen Baylin United States
James F. Powers United States
David A. Eberhard relative to J. Guillermo Paez United States J. Guillermo Paez's profile →
Citations per field
00.5×2×3×4.0×
J. Guillermo Paez · 1×
Citations per year

Countries citing papers authored by David A. Eberhard

Since Specialization
Citations

This map shows the geographic impact of David A. Eberhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Eberhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Eberhard more than expected).

Fields of papers citing papers by David A. Eberhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Eberhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Eberhard. The network helps show where David A. Eberhard may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Eberhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Eberhard Line = papers co-authored together David A. Eberhard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
Hit paper breakdown →
20051260
2
Diverse somatic mutation patterns and pathway alterations in human cancers
Hit paper breakdown →
2010891
3
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
Hit paper breakdown →
2005488
4 2005443
5 2005397
6 1997286
7 2008264
8 1988224
9
Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
2000210
10 2006207
11 1990204
12 2013198
13 1989193
14 2017144
15
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
2002125
16 1987122
17 2012112
18 2013110
19
Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus.
1994105
20 2009105

About David A. Eberhard

David A. Eberhard is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Cell Biology, having authored 51 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), AI in cancer detection (3 papers), Cellular transport and secretion (3 papers), Glioma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Genetics (447 citations), Cancer Research (666 citations), Oncology (1.1k citations) and Cell Biology (455 citations). David A. Eberhard has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Ronald W. Holz, Bruce Evan Johnson, Somasekar Seshagiri, Lukas C. Amler, Thomas Januario, Jeremy Stinson, Ladislau E. Steiner, Roy S. Herbst, Bernard F. Schneider and David H. Johnson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Applied immunohistochemistry & molecular morphology, Nature and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact